Immunotherapeutic aryl amides
US6046221A · kind A · utility
54Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 1998 |
| Grant date | Apr 4, 2000 |
| Priority date | — |
| Expiry date | Aug 25, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel aryl amides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.